Business Context and Reporting Period
This Form 8-K is filed by Second Sight Medical Products, Inc. (not Vivani Medical, Inc.) on May 15, 2019. The report announces financial results for the three-month period ended March 31, 2019. The company is incorporated in California and its common stock (EYES) and warrants (EYESW) trade on the NASDAQ.
Key Financial Metrics
The filing text serves as a cover document referencing an attached earnings release (Exhibit 99.1) for detailed data. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the attached Exhibit 99.1 for specific financial figures.
Material Changes
The filing text does not contain specific data regarding material changes versus the prior comparable period. It only confirms the announcement of results for the quarter ended March 31, 2019.
Guidance, Outlook, and Risks
The filing text does not include management commentary, guidance, outlook, or specific risk factors. It notes that the information furnished in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Important Facts for Investor Verification
- Verify the specific financial results (revenue, net loss, cash position) in the attached Exhibit 99.1, as they are not listed in the 8-K body.
- Confirm the company name is Second Sight Medical Products, Inc., as the request metadata incorrectly listed "Vivani Medical, Inc."
- Note that the earnings release is furnished but not "filed" under Section 18 of the Exchange Act, limiting liability protections for the data within.
- Check the status of the company's warrants (EYESW) trading on NASDAQ alongside common stock.